Largest analysis of hydroxychloroquine use finds no benefit for coronavirus, increased deaths | TheHill
An anti-malaria drug touted by President Trump as a potential “game changer” amid the coronavirus outbreak showed no benefit for patients, according to an analysis of those hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for COVID-19 patients treated with hydroxychloroquine were death and the need for mechanical ventilation.